No Detail Found!

Comparison of potential plasma biomarkers in Alzheimer's disease and neurodegenerative dementias in Pakistani population

Author(s)
Tehniat Faraz Ahmed Department of Biochemistry, Dow International Dental College, Dow University of Health Sciences, Karachi, Pakistan
Fauzia Imtiaz Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
Uzma Zaman Department of Biochemistry, Dow International Medical College, Dow University of Health Sciences, Karachi, Pakistan
Affan Ahmed Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan
Naila Shahbaz Department of Neurology, Civil Hospital, Karachi, Pakistan.
Abstract
This study aimed to compare the mean plasma levels of Amyloid ß42, Phosphorylated Tau and Neurofi lament Light chain in patients diagnosed with Alzheimer's Clinical Syndrome (ACS), and other neurodegenerative dementias to fi nd affordable and less-invasive means of diagnosing Alzheimer's disease (AD) early in its course. Blood samples of 36 subjects presenting with cognitive decline to the neurology OPDs of Dow and Civil hospitals, Karachi, were centrifuged, and plasma was stored at -80?. Before analysis, it was thawed at 4? and protein levels were measured through ELISA. Two-thirds of the patients were females but age distribution across both the groups was not signifi cantly different (p=0.21). No difference was observed in the mean plasma concentrations of Aß42, P-Tau, and NFL between the two groups (p-values 0.78 and 0.27 and 0.09 respectively). Our study suggests that despite being promising in CSF, Aß42, P-Tau, and NFL cannot differentiate between different neurodegenerative dementias when measured in plasma.
Publication Details
Page(s) 2062-2064
Published Journal: Journal of Pakistan Medical Association, Volume: 73, Issue: 10, Year: 2023

Request the full text from PASTIC

Keywords
biomarkers, Alzheimer disease, Neurofi lament proteins, Tau proteins, Amyloid beta peptides
0

Citations

0

Downloads

90

Views